Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Nov 7, 2019, after the close
10-Q filed Nov 7, 2019, 38 days after period end · 0001299130-19-000053
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $21.92M | $18.16M | $23.55M | $25.12M |
| Net Income | -$29.12M | -$25.04M | -$22.02M | -$17.49M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.19 |
| -$0.19 |
| -$0.19 |
| -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
